2014
DOI: 10.1093/jjco/hyu127
|View full text |Cite
|
Sign up to set email alerts
|

EBM-based Clinical Guidelines for Pancreatic Cancer (2013) Issued by the Japan Pancreas Society: A Synopsis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
4
2

Relationship

2
4

Authors

Journals

citations
Cited by 38 publications
(30 citation statements)
references
References 0 publications
0
30
0
Order By: Relevance
“…In 2013, JPS published clinical guidelines (CGL) for PC based on evidence‐based medicine 14. This CGL provides an algorithm for the diagnosis and treatment of PC including 35 clinical questions and 57 recommendations.…”
Section: Risk Factors and Early Diagnosismentioning
confidence: 99%
See 1 more Smart Citation
“…In 2013, JPS published clinical guidelines (CGL) for PC based on evidence‐based medicine 14. This CGL provides an algorithm for the diagnosis and treatment of PC including 35 clinical questions and 57 recommendations.…”
Section: Risk Factors and Early Diagnosismentioning
confidence: 99%
“…These observations suggest that EUS should have important roles in the early diagnosis of PC. Recently, JPS first published a recommendation for early diagnosis of PC with a favorable long prognosis in the current CGL as follows 14. Dilatation of the main pancreatic duct and the presence of cysts are important indirect signs.…”
Section: Algorithms Of Image Diagnosis For Early Pcmentioning
confidence: 99%
“…In Japan, the clinical guidelines for PC based on evidencebased medicine were published by the Japan Pancreas Society (JPS) in 2006 and were revised to the third version in 2013 [6]. The guidelines show an algorithm for the diagnosis and treatment of PC.…”
Section: Risk Factors For Pcmentioning
confidence: 99%
“…A multicenter study from a working group of the JPS recently reported that PC distinct from branch duct IPMNs developed in seven (2.0 %) of 349 patients during the follow-up period (median 3.7 years) [10]. From these reports, the guidelines recommended that IPMNs and pancreatic cysts should be carefully followed as premalignant diseases of PC [6]. Additionally, another JPS working group reported that PC concomitant with IPMN may have more favorable biological behaviors or may be diagnosed earlier than ordinary PC [11].…”
Section: Risk Factors For Pcmentioning
confidence: 99%
See 1 more Smart Citation